Skip to main navigation Skip to search Skip to main content

Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol

  • R. J. Gralla
  • , L. B. Tyson
  • , L. A. Bordin
  • , R. A. Clark
  • , D. P. Kelsen
  • , M. G. Kris
  • , L. B. Kalman
  • , S. Groshen

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of this paper is twofold. First we report the results of a recently completed study in which two frequently used agents, metoclopramide and delta-9-tetrahydrocannabinol (THC), were compared. Second, we review recent trials with several antiemetic agents and examine trends observed in current antiemetic clinical research.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalCancer Treatment Reports
Volume68
Issue number1
StatePublished - 1984
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol'. Together they form a unique fingerprint.

Cite this